True but they gave themselves a lot of those shares, so they didn't exactly pay for them the way we did and they can, and undoubtedly will, give themselves more shares, while we will have to continue to buy ours. I guarantee their percentage of the firm will not decrease as rapidly as will ours.
They seem quite focused on the medical community and other pharmaceutical companies, which is great. The problem is that they seem out-of-touch with retail investors' needs and feelings and if they need to rely on new retail interest to raise or maintain share price, that may hinder their efforts. I would love to post a one-page DD on reddit or other forums I know, explaining the opportunity right now with a guaranteed success and artificially depressed share price but I have no confidence currently that the company can meet any sort of near-term goals in a timely manner. It is very frustrating.
News 
Market Data 
Discover 
